Harris, Violaine K.
Stark, James
Williams, Armistead
Roche, Morgan
Malin, Michaela
Kumar, Anjali
Carlson, Alyssa L.
Kizilbash, Cara
Wollowitz, Jaina
Andy, Caroline
Gerber, Linda M.
Sadiq, Saud A.
Funding for this research was provided by:
National Multiple Sclerosis Society (National Multiple Sclerosis Society)
Biogen (Biogen)
Article History
Received: 19 January 2024
Accepted: 18 May 2024
First Online: 23 May 2024
Declarations
:
: The study entitled “Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally” was approved on 11/28/2016 by Western Institutional Review Board (reference number 20162572). All patients gave written informed consent.
: VH and SS are listed as inventors on a US patent issued to the Tisch MS Research Center of New York and is considered a non-financial competing interest. All other authors declare no competing interests.